MOREPENLAB vs WANBURY: Stock Comparison

Morepen Laboratories Limited vs Wanbury Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Morepen Laboratories Limited is the larger company by market capitalisation. Morepen Laboratories Limited shows a higher dividend yield, faster revenue growth and lower leverage, while Wanbury Ltd shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Morepen Laboratories Limited and Wanbury Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, MOREPENLAB is more favourable on 3 of 13 scored metrics and WANBURY on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
MOREPENLAB is the larger company
₹3,035 Cr vs ₹1,091 Cr
P/E Ratio
WANBURY has a lower P/E
0x vs 31.96x
P/B Ratio
WANBURY has a lower P/B
0x vs 2.43x
EPS
WANBURY has higher earnings per share
₹13.1 vs ₹1.79
Dividend Yield
MOREPENLAB has a higher dividend yield
0.33% vs 0%
Revenue Growth (TTM YoY)
MOREPENLAB has faster revenue growth
4% vs -19.2%
EPS Growth (TTM YoY)
WANBURY has faster EPS growth
0% vs -18.9%
Qtr Sales Growth
WANBURY has stronger quarterly sales growth
24.5% vs 4.05%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMOREPENLABWANBURY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMOREPENLABWANBURY
Live Price₹55.3₹312.45
Day Change-2.4%-5.1%
Volume30.92 L2.85 L
52-Week High₹64.58₹358.85
52-Week Low₹33.05₹161.5
Distance from 52W High-14.37%-12.93%

Valuation

MetricMOREPENLABWANBURY
Market Cap₹3,035 Cr₹1,091 Cr
P/E Ratio31.96x0x
P/B Ratio2.43x0x
EPS₹1.79₹13.1
Book Value₹22.17₹18.1
Dividend Yield0.33%0%

Growth

MetricMOREPENLABWANBURY
Revenue Growth (TTM YoY)4%-19.2%
EPS Growth (TTM YoY)-18.9%0%
Qtr Sales Growth4.05%24.5%
Qtr Profit Growth-22.5%1,197%

Profitability & Leverage

MetricMOREPENLABWANBURY
ROE6.2%76.5%
ROCE8.05%36.6%
Net Margin5.25%10.17%
Operating Margin6.96%14%
Debt to Equity0.17x3.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMOREPENLABWANBURY
Promoter Holding35.65%34.36%
FII Holding1.46% 0.12 pp0.89% 0.3 pp
DII Holding1.28% 0.03 pp0.06% 0.06 pp
Public Holding61.59% 0.09 pp56.03% 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Morepen Laboratories Limited and Wanbury Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.